Global Isobutylamido Thiazolyl Resorcinol market was valued at USD 3.2 million in 2024 and is expected to reach USD 5.7 million by 2032, growing at a CAGR of 8.2% during the forecast period. Isobutylamido Thiazolyl Resorcinol (INCI: Thiamidol 630) is a clinically proven skin-brightening active ingredient developed by Beiersdorf AG, functioning as a potent tyrosinase inhibitor. This synthetic...